Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease. (March 2017)

• Record Type: Journal Article
• Authors: Ankersen, Dorit Vedel; Carlsen, Katrine; Marker, Dorte; Munkholm, Pia; Burisch, Johan
• Other Names: Gibson Peter guestEditor.; Muir Jane guestEditor.
• Is Part Of: Journal of gastroenterology and hepatology. Volume 32(2017)Supplement 1
• Page Start: 27
• Page End: 31
• Publication Date: 2017-03
• Subjects: diet -- inflammatory bowel disease and irritable bowel syndrome -- patient compliance -- telemedicine; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.13691
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Health‐care systems around the world are facing increasing costs. Non‐adherent, chronically ill patients are one such expense incurred by health‐care providers. Web‐based home‐monitoring of patients—or eHealth—has been shown to increase adherence to medical therapy, facilitate contact between patients and health‐care professionals, and reduce time to remission for patients with inflammatory bowel disease (IBD). Web‐based treatment is a supportive tool for the health‐care provider in an out‐patient clinic. eHealth web‐programs, such as the Constant Care application, visualize disease activity in a traffic light system and empower patients to screen for disease activity, enabling them to respond appropriately to their symptoms. The eHealth screening procedure for monitoring both pediatric and adult IBD patients is based on a self‐obtained symptom score, together with a fecal biomarker for inflammation (fecal calprotectin) that the patients can measure independently using their smart phone, providing both patient and physician with an immediate disease status that they can react to instantaneously. Likewise, web applications for IBD patients, web applications for irritable bowel syndrome (IBS) patients and also IBD patients with co‐existing IBS, have proven valuable for monitoring and treating IBS symptoms with a diet low in fermentable oligo‐, di‐, monosaccharides and polyols (low‐FODMAP diet). With careful disease monitoring via the web application and increased patient adherence, eHealth might be capable of improving the natural disease course of IBD and IBS.